Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

Positively charged. Nine million Americans live with a chronic cough that persists despite treatment or has no identifiable cause.

News

Blog 3 months ago
Nocion Therapeutics Announces Upcoming Poster Presentation at the ERS Cough Conference 2026
The post Nocion Therapeutics Announces Upcoming Poster Presentation at the ERS Cough Conference 2026 appeared first on Nocion Therapeutics.
Read more
Report
Blog 5 months ago
Nocion Therapeutics Appoints Vineet Agarwal as Chief Business Officer
The post Nocion Therapeutics Appoints Vineet Agarwal as Chief Business Officer appeared first on Nocion Therapeutics.
Read more
Report
Blog 5 months ago
Nocion Therapeutics Announces Full Enrollment in Phase 2b ASPIRE Study of Taplucainium for Chronic Cough
The post Nocion Therapeutics Announces Full Enrollment in Phase 2b ASPIRE Study of Taplucainium for Chronic Cough appeared first on Nocion Therapeutics.
Read more
Report
Blog 6 months ago
Nocion Therapeutics Strengthens Board of Directors with Appointment of Mark Iwicki
The post Nocion Therapeutics Strengthens Board of Directors with Appointment of Mark Iwicki appeared first on Nocion Therapeutics.
Read more
Report
Blog 9 months ago
Nocion Therapeutics to Present Preclinical Data Supporting Nocions as a Novel Approach for the Treatment of Pain at the Non-Opioid Pain Therapeutics Summit
The post Nocion Therapeutics to Present Preclinical Data Supporting Nocions as a Novel Approach for the Treatment of Pain at the Non-Opioid Pain Therapeutics Summit appeared first on Nocion Therapeutics.
Read more
Report
Blog 1 year ago
Nocion Therapeutics Appoints Matthew Frankel, M.D., MBA to Chief Medical Officer
The post Nocion Therapeutics Appoints Matthew Frankel, M.D., MBA to Chief Medical Officer appeared first on Nocion Therapeutics.
Read more
Report
Blog 2 years ago
Nocion Therapeutics Announces First Patient Dosed in ASPIRE Phase 2b Chronic Cough Study
The post Nocion Therapeutics Announces First Patient Dosed in ASPIRE Phase 2b Chronic Cough Study appeared first on Nocion Therapeutics.
Read more
Report
Blog 2 years ago
Nocion Therapeutics Presents Data on Preclinical and Clinical Development of Taplucainium, a Novel, Charged Sodium Channel Blocker, as a potential treatment for Chronic Cough at the 13th London International Cough Symposium
The post Nocion Therapeutics Presents Data on Preclinical and Clinical Development of Taplucainium, a Novel, Charged Sodium Channel Blocker, as a potential treatment for Chronic Cough at the 13 th London International Cough Symposium appeared first on Noc
Read more
Report
Blog 2 years ago
Nocion Therapeutics Appoints Dr. Catherine Bonuccelli to Scientific Advisory Board and Joan Shaw to Senior Vice President, Clinical Operations
The post Nocion Therapeutics Appoints Dr. Catherine Bonuccelli to Scientific Advisory Board and Joan Shaw to Senior Vice President, Clinical Operations appeared first on Nocion Therapeutics.
Read more
Report
Show more news